A*STAR researchers have shown that the RASAL2 gene, which is known to inhibit tumor growth in some breast cancers, actually advances tumor formation and metastasis in more aggressive forms of breast cancer and have suggested ...
May 27, 2015
0
16
Ovarian cancer often remains undetected until it is at an advanced stage. Despite positive responses to initial treatment, many patients are at risk of tumor recurrence. A multitude of genetic markers have been implicated ...
Aug 15, 2013
0
0
Of all gastrointestinal cancers, pancreatic cancer is one of the most aggressive. Because of this, it has a very low 5-year survival rate of just 5% and a median survival time below 6 months. Additionally, treatment is difficult, ...
Jan 24, 2019
0
2
(Medical Xpress)—A cure for congenital sight impairment caused by lens damage is closer following research by scientists at Monash University.
Jan 31, 2013
1
0
Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas ...
Aug 26, 2013
0
0
A blood test may have the potential to speed accurate diagnosis - and proper treatment - of bipolar disorder in children, new research suggests.
Apr 5, 2018
0
29
(HealthDay) -- Resistance training (RT) can reduce visceral fat and alter levels of certain inflammatory markers, according to research published in the July issue of Obesity Reviews.
Jul 12, 2012
0
0
The accumulation of β-Amyloid (Αβ) and tau proteins in the brain is hallmark pathology for Alzheimer disease. Recently developed positron emission tomography (PET) tracers, including [18F]-AV-1451, bind to tau in neurofibrillary ...
Jul 25, 2016
0
1
A small University at Buffalo study has found for the first time that in Type 1 diabetics, insulin injections exert a strong anti-inflammatory effect at the cellular and molecular level, while even small amounts of glucose ...
May 16, 2013
0
0
Epstein-Barr virus (EBV) is the cause of infectious mononucleosis and a risk for serious disease in liver transplant recipients. Molecular tests that can identify early protein markers produced by EBV may have value for diagnosing ...
Nov 16, 2012
0
0
